BiDil : N Y Times Sees Threat to Multiculturism

The FDA approved BiDil, a particularly effective treatment againt heart failure in African-Americans-the first race based drug. This should be welcomed as good progress. But some see a threat. For example, the N Y Times June 19, 2005 editorial. The editor twists the drugs approval into a speculation on social ramifications. The high priests of multiculturism perceive a threat to their dreams of a society which has no class and no culture. They wring their editorial hands over how the testing could have been expanded to make sure other races could be included. Are editors implying that the Nazis and the Fascists started this way?

Simply, NitroMed did not have the money for an extended market test. The company went to the FDA with the results they had-it will help African-Americans now. Not enough for the N Y Times. Any narrow based drugs must take into account social implications-everyone must advance or nobody should advance.

This is science where differences are measured. Social mechanics want to overlook differences. The best advice is never to overlook differences.